Zevra Therapeutics, Inc. ZVRA Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s operating lease liabilities (current)?
- Zevra Therapeutics, Inc. (ZVRA) reported operating lease liabilities (current) of $406K in Q1 2026.
- How has Zevra Therapeutics, Inc.'s operating lease liabilities (current) changed year-over-year?
- Zevra Therapeutics, Inc.'s operating lease liabilities (current) decreased by 31.1% year-over-year, from $589K to $406K.
- What is the long-term trend for Zevra Therapeutics, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s operating lease liabilities (current) has grown at a 5.1% compound annual growth rate (CAGR), from $327K to $419K.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.